Table 4
National SARS-CoV-2 antibody seroprevalence estimates, by antibody seroprevalence type and visible minority status
| Antibody seroprevalence overall percentage | Low 95% Confidence Interval | High 95% Confidence Interval | Antibody seroprevalence due to infection percentage | Low 95% Confidence Interval | High 95% Confidence Interval | Antibody seroprevalence due to vaccination percentage | Low 95% Confidence Interval | High 95% Confidence Interval | |
|---|---|---|---|---|---|---|---|---|---|
| Visible Minority | 4.8 | 3.1 | 6.8 | 4.3 | 2.6 | 6.3 | 0.5 | 0.0 | 1.2 |
| Not a Visible Minority | 3.3 | 2.3 | 3.9 | 2.1 | 1.1 | 2.6 | 1.2 | 0.2 | 1.5 |
Source(s):
Statistics Canada; Canadian COVID-19 Antibody and Health Survey (5339).
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: